AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
49 hedge funds and large institutions have $33.2M invested in AVEO Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 44 → 49 (+5)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
49
Holding in Top 10
1
Calls
$9K
Puts
$3K
Top Buyers
| 1 | +$3.54M | |
| 2 | +$2.83M | |
| 3 | +$2.32M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.71M |
| 5 |
6CM
683 Capital Management
New York
|
+$1.35M |
Top Sellers
| 1 | -$405K | |
| 2 | -$229K | |
| 3 | -$128K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$127K |
| 5 |
SIM
Spark Investment Management
New York
|
-$51K |